Vieira Roberto Wandenkolk
President, Oncology
Vieira Roberto Wandenkolk has filed 1 SEC Form 4 filing (11 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Vieira Roberto Wandenkolk is listed as President, Oncology at CORCEPT THERAPEUTICS INC. Inside the rolling window, Vieira Roberto Wandenkolk reported no open-market purchases and 1 open-market sale totaling $6.5M in CORT.
Companies traded
Other insiders at CORT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Vieira Roberto Wandenkolk made?
Vieira Roberto Wandenkolk has filed 1 SEC Form 4 filing (11 transaction rows) across 1 company since 2026.
Which companies does Vieira Roberto Wandenkolk trade?
Vieira Roberto Wandenkolk has filed SEC Form 4 disclosures for 1 company, including CORT.
When was Vieira Roberto Wandenkolk's most recent SEC Form 4 filing?
Vieira Roberto Wandenkolk's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Vieira Roberto Wandenkolk's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Vieira Roberto Wandenkolk is listed as President, Oncology.
What is Vieira Roberto Wandenkolk's total buy and sell value in the current window?
Inside the rolling retention window, Vieira Roberto Wandenkolk bought $0 and sold $6.5M based on SEC Form 4 filings.
What was Vieira Roberto Wandenkolk's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 58,333 CORT shares on 2026-09-02, worth $6.5M, per SEC Form 4 filings.